Frontlight ResearchEarly access
Not yet recruitingPhase 2
SHIELD – Swift Hydrocortisone Intervention after trauma exposure
Key facts
- Who runs it
- Amsterdam UMC Stichting
- Where
- Netherlands4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 196 people, planned
- Started
- 1 Jan 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional
- Record updated
- 13 July 2026
Who can take part
- Age
- 18 years to 64 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Age: 18 to 65
- Sex/gender: any
- Proficiency in Dutch
- Presented at ED as a result of a one-time incident involving injury as a result of an accident, physical or sexual violence or another kind of exceptional situation
Who cannot take part
- Psychiatric counterindications assessed through anamnesis
- Not able to give informed consent
- Not allowed to take hydrocortisone
- Practical exclusion criteria (e.g., no reliable access to telephone or internet)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Posttraumatic stress disorder
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main objective is to investigate whether hydrocortisone, compared to placebo, leads to lower clinician-assessed PTSD symptomology 3 months after trauma.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
Download the PDF
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Criteria questions
- Built from 2025-523350-13-02, who can take part
- Record updated
- 13 July 2026